IP Library Granted Patent US 10,265,542
Granted Patent B2
US 10,265,542 · App. 15/349,455 · Granted Apr 23, 2019

Dosimetrically customizable brachytherapy carriers and methods thereof in the treatment of tumors

Inventors: David Brachman (Phoenix, AZ); Peter Nakaji (Phoenix, AZ); Heyoung McBride (Phoenix, AZ); Emad Youssef (Peoria, AZ); Theresa Thomas (Gilbert, AZ)
Assignee: GT MEDICAL TECHNOLOGIES, INC.
A61N5/1007A61N5/1015A61N2005/1011A61N2005/1024
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,265,542
App. No.
15/349,455
Granted
Apr 23, 2019
Kind
B2
Abstract

Brachytherapy radioisotope carrier systems and methodology for providing real-time customized brachytherapy treatment to subjects with tumors difficult to control using conventional radiation therapy techniques. The invention generally relates to devices, methods and kits for providing customized radionuclide treatments, to help cure, slow progression or regrowth, or ameliorate the symptoms associated with tumors.

Claims (25)

1. A treatment system comprising:

an introducer adapted to engage with a radioactive seed carrier to maintain position of the radioactive seed carrier with reference to the introducer while the radioactive seed carrier is implanted into a cavity of a mammal, wherein the radioactive seed carrier is permanently implantable into the mammal and the introducer is removable from the radioactive seed carrier after implantation of the radioactive seed carrier into the mammal;

the radioactive seed carrier comprising:

an engagement interface configured to engage with the introducer; and

one or more flexible elongate members each having:

a proximal end;

a distal end; and

a carrier portion between the proximal end and the distal end, the carrier portion embedding a radioactive seed;

wherein the radioactive seed carrier is adapted to transform between a first state and a second state in response to movement of the introducer engaged with the engagement interface of the radioactive seed carrier, wherein

the first state is adapted to maintain the one or more flexible elongate members in a substantially linear arrangement; and

the second state is attained by flexing each of the one or more flexible elongate members to engage with one or more surfaces of the cavity.

2. The treatment system of claim 1 , wherein the introducer is manually controlled.

3. The treatment system of claim 1 , wherein the introducer is robotically controlled.

4. The treatment system of claim 1 , wherein the second state is a substantially symmetrical shape.

5. The treatment system of claim 1 , wherein the second state is asymmetrical.

6. The treatment system of claim 1 , wherein the second state is asymmetrical and substantially matches an asymmetrical shape of the cavity.

7. The treatment system of claim 1 , wherein the proximal ends of the flexible elongate members are not attached to one another.

8. The treatment system of claim 1 , wherein the proximal ends of at least some of the flexible elongate members are attached to one another.

9. The treatment system of claim 1 , wherein at least one of the flexible elongate members comprises a trim indicator of a location where trimming of the at least one of the flexible elongate members may be performed without impacting the embedded radioactive seed.

10. The treatment system of claim 9 , wherein the carrier portion of the at least one of the flexible elongate members includes a second radioactive seed and the trim indicator is located between the radioactive seed and the second radioactive seed.

11. The treatment system of claim 1 , wherein the radioactive seed carrier comprises four flexible elongate members that are each flexible about the engagement interface such that the second state of the radioactive seed carrier comprises five sides.

12. The treatment system of claim 1 , wherein the radioactive seed carrier is formed of a biocompatible material.

13. The treatment system of claim 1 , wherein the radioactive seed carrier is formed of collagen.

14. The treatment system of claim 1 , wherein the one or more flexible elongate members have a thickness of between about one millimeter and about eight millimeters.

15. The treatment system of claim 1 , wherein the one or more flexible elongate members have a thickness of about one millimeter.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 1, 2018
From: NAKAJI, PETER; BRACHMAN, DAVID; MCBRIDE, HEYOUNG; YOUSSEF, EMAD; THOMAS, THERESA
To: GAMMATILE LLC
Reel/Frame 045962/0836 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 29, 2017
From: GAMMATILE, LLC
To: GT MEDICAL TECHNOLOGIES, INC.
Reel/Frame 044250/0226 →
Continuity (3)
Continuation 14216723 · Mar 17, 2014
Provisional Application 61800983 · Mar 15, 2013
Related Publication 20170120073A1 · May 4, 2017
Cited By (4)
US 12,478,800 US 12,636,387 US 12,654,030 US 12,708,795